These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18824861)

  • 21. Magnesium sulphate for treatment of eclampsia: the Nigerian experience.
    Adewole IF; Oladokun A; Okewole AI; Omigbodun AO; Afolabi A; Ekele B; Audu LR; Obed Y
    Afr J Med Med Sci; 2000; 29(3-4):239-41. PubMed ID: 11713998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia.
    Sibai BM; Lipshitz J; Anderson GD; Dilts PV
    Obstet Gynecol; 1981 Feb; 57(2):199-202. PubMed ID: 7465124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of magnesium sulfate on electroencephalographic findings in preeclampsia-eclampsia.
    Sibai BM; Spinnato JA; Watson DL; Lewis JA; Anderson GD
    Obstet Gynecol; 1984 Aug; 64(2):261-6. PubMed ID: 6738959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. India needs to upscale magnesium sulphate use for management of eclampsia.
    Singh S; Chandhiok N; Dhillon BS
    J Obstet Gynaecol Res; 2011 Jun; 37(6):667-9. PubMed ID: 21564415
    [No Abstract]   [Full Text] [Related]  

  • 25. Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension.
    Alexander JM; McIntire DD; Leveno KJ; Cunningham FG
    Obstet Gynecol; 2006 Oct; 108(4):826-32. PubMed ID: 17012442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resident training for eclampsia and magnesium toxicity management: simulation or traditional lecture?
    Fisher N; Bernstein PS; Satin A; Pardanani S; Heo H; Merkatz IR; Goffman D
    Am J Obstet Gynecol; 2010 Oct; 203(4):379.e1-5. PubMed ID: 20691408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic magnesium sulphate in prevention of eclampsia in women with severe preeclampsia: randomised controlled trial (PIPES trial).
    Keepanasseril A; Maurya DK; Manikandan K; Suriya J Y; Habeebullah S; Raghavan SS
    J Obstet Gynaecol; 2018 Apr; 38(3):305-309. PubMed ID: 28974124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of intramuscular loading dose of MgSO4 in severe pre-eclampsia/ eclampsia at a tertiary referral centre in Northwest Nigeria.
    Okusanya BO; Garba KD; Ibrahim HM
    Niger Postgrad Med J; 2012 Jun; 19(2):77-82. PubMed ID: 22728971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen.
    Das M; Chaudhuri PR; Mondal BC; Mitra S; Bandyopadhyay D; Pramanik S
    Indian J Pharmacol; 2015; 47(5):502-8. PubMed ID: 26600638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loading Dose only versus Standard Dose Magnesium Sulfate Seizure Prophylaxis in Severe Pre-eclamptic Women.
    Rimal SP; Rijal P; Bhatt R; Thapa K
    JNMA J Nepal Med Assoc; 2017; 56(208):388-94. PubMed ID: 29453467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eclampsia : before and after magnesium sulphate.
    Chaudhary P
    JNMA J Nepal Med Assoc; 2005; 44(160):124-8. PubMed ID: 16751814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Magnesium sulfate is recommended against eclampsia].
    Hjertberg R
    Lakartidningen; 1999 Jan; 96(4):356-7. PubMed ID: 10024827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of 10gram intramuscular loading dose of MgSO(4) in severe preeclampsia/ eclampsia at a tertiary referral centre in Northwest Nigeria.
    Okusanya BO; Garba KK; Ibrahim HM
    Niger Postgrad Med J; 2012 Sep; 19(3):143-8. PubMed ID: 23064169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eclampsia--management and outcome with magnesium sulphate as the anticonvulsant.
    Naz T; Mehr-un-Nisa ; Hassan L
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):624-7. PubMed ID: 19810301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-labelled randomised controlled trial of 12 hours versus 24 hours modified Pritchard regimen in the management of eclampsia and pre-eclampsia in Ghana (MOPEP Study): study protocol.
    Beyuo T; Lawrence E; Langen ES; Oppong SA
    BMJ Open; 2019 Oct; 9(10):e032799. PubMed ID: 31641005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial.
    Lancet; 1995 Jun; 345(8963):1455-63. PubMed ID: 7769899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is serum magnesium estimate necessary in patients with eclampsia on magnesium sulphate?
    Ekele BA; Badung SL
    Afr J Reprod Health; 2005 Apr; 9(1):128-32. PubMed ID: 16104662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management.
    Smith JM; Lowe RF; Fullerton J; Currie SM; Harris L; Felker-Kantor E
    BMC Pregnancy Childbirth; 2013 Feb; 13():34. PubMed ID: 23383864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Audit can ensure the safe and effective introduction of seizure prophylaxis with magnesium sulphate in obstetric practice.
    Owen P
    Health Bull (Edinb); 2000 Sep; 58(5):414-7. PubMed ID: 12813796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study.
    Salinger DH; Mundle S; Regi A; Bracken H; Winikoff B; Vicini P; Easterling T
    BJOG; 2013 Jun; 120(7):894-900. PubMed ID: 23530757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.